HSP90AA1 and cancer: Certainly, there have been a number of efforts to improve treatment options for cancer, most notably by exploring various inhibitors (most recently HSP90 C-terminal inhibitors) in order to understand the molecular and cellular determinants harboring any clinical relevance [4,5,6].